Skip to content

    Recently Viewed

      Listening...

      Johnson & Johnson Launches Illustrate Change, an Initiative to Increase Diversity and Representation in Medical Illustrations

      Share Article
      share to

      New Brunswick, NJ (June 20, 2023) - Johnson & Johnson (NYSE: JNJ) today announced the launch of Illustrate Change, a new initiative that aims to increase diversity and representation in medical illustrations. The initiative includes a growing library of diverse medical illustrations, a fellowship to support the future of medical illustrators of color, and an awareness campaign to help bring lasting change in the U.S. healthcare system and vision for a more inclusive future for patients of color.

      Vanessa Broadhurst, Executive Vice President of Global Corporate Affairs for Johnson & Johnson, issued the following statement:

      “The lack of representation in medical imagery is an issue that directly impacts communities of color and their relationship with the healthcare system. This can lead to feelings of not being seen and continue potential mistrust among communities of color. To that end, our fellowship with the Association of Medical Illustrators is a unique component of Johnson & Johnson’s commitment to addressing racial biases in medicine, increasing representation in healthcare, and promoting health equity so that all communities can thrive.”

      Illustrate Change is part of Johnson & Johnson’s Our Race to Health Equity (ORTHE), a bold commitment to create a world where the color of your skin is not a determinant of your access to care, quality of care or health outcomes. The new project is presented in collaboration with illustrator Chidiebere Ibe, Deloitte and the Association of Medical Illustrators. Learn more about the initiative and see the full library at www.IllustrateChange.com. Read more information about the AMI Fellowship at ami.org/.

      Media Contact:
      media-relations@its.jnj.com

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.